Some comments on efficiency gains from auxiliary information for right-censored data
From MaRDI portal
Publication:5939500
DOI10.1016/S0378-3758(00)00335-9zbMath0971.62055OpenAlexW2049409424MaRDI QIDQ5939500
No author found.
Publication date: 4 October 2001
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0378-3758(00)00335-9
Applications of statistics to biology and medical sciences; meta analysis (62P10) Censored data models (62N01)
Related Items
A Shrinkage Approach for Estimating a Treatment Effect Using Intermediate Biomarker Data in Clinical Trials ⋮ Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model ⋮ Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial ⋮ Landmark estimation of survival and treatment effects in observational studies
Cites Work
- A note on the asymptotic variance of survival function in the semi-Markov model
- A comment on the use of auxiliary or surrogate outcome data
- Auxiliary outcome data and the mean score method
- Inference using surrogate outcome data and a validation sample
- A Stochastic Model for Censored-Survival Data in the Presence of an Auxiliary Variable
- Using Auxiliary Variables for Improved Estimates of Survival Time
- Using surrogate failure time data to increase cost effectiveness in clinical trials
- A kernel method for incorporating information on disease progression in the analysis of survival
- Nonparametric Survival Estimation Using Prognostic Longitudinal Covariates
- Miscellanea. Semiparametric two-sample tests in clinical trials with a post-randomisation response indicator
- A modification of the redistribution to the right algorithm using disease markers
- Maximum Likelihood Estimation of Misspecified Models
- Statistical models based on counting processes
